Table 2. Sequencing of ALK-TKI.
| Crizotinib | Ceritinib | Alectinib | Lorlatinib | Chemotherapy* | |
|---|---|---|---|---|---|
| First line | 27 | 4 | 0 | – | 7 |
| Second line | 6 | 16 | 2 | 11 | 3 |
| Third line | – | 4 | 0 | 21 | 3 |
| Fourth line | – | 1 | 1 | 4 | 2 |
| Later lines | _ | _ | _ | 2 | 2 |
ALK, anaplastic lymphoma kinase; TKI, tyrosine kinase inhibitor
Chemotherapy regimen was platinum based- either with pemetrexed or paclitaxel